PIK3CD and neoplasm: Overexpression of miR-1224-5p targets PLK1, reduces the phosphorylation of PI3K, Akt, and mTOR, and negatively regulates the PI3K/Akt/mTOR pathway, and inhibits tumor growth and EMT.